EMEA-000892-PIP01-10

Key facts

Active substance
  • Clindamycin phosphate
  • Tretinoin
Therapeutic area
Dermatology
Decision number
P/160/2010
PIP number
EMEA-000892-PIP01-10
Pharmaceutical form(s)
Gel
Condition(s) / indication(s)
Treatment of acne vulgaris
Route(s) of administration
Cutaneous use
Contact for public enquiries
MEDA Pharma GmbH & Co. KG
info@medapharma.de
Country: Germany
Phone: +49 617288801
Fax: +49 61728881112
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Compliance procedure number
EMEA-C-000892-PIP01-10
Compliance opinion date
10/12/2010
Compliance outcome
positive

Decision

How useful was this page?

Add your rating